fls.txt
Actual events in the future could differ materially from those described in the forward-looking information.


item1.txt
All material intercompany balances and transactions have been eliminated.
In February 2016, the FASB issued ASU No.
The FASB issued this update to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements.
Early adoption of the update is permitted.
The Company is currently evaluating the effect of the new standard.
In August 2016, the FASB issued ASU 2016-15, “Classification of Certain Cash Receipts and Cash Payments”.
This update provides guidance on how to record eight specific cash flow issues.
In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230)”, requiring that the statement of cash flows explain the change in the total cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents.
On December 22, 2017, the Staff of the Securities and Exchange Commission issued Staff Accounting Bulletin No.
We expect to complete our accounting during the one year measurement period from the enactment date.
For the three months ended December 31, 2017 and 2016, respectively, two customers accounted in the aggregate for approximately 10% and 17% of net sales of the Benchtop Laboratory Equipment Operations (15% and 9% of the Company’s total revenues).
For the six months ended December 31, 2017 and 2016, respectively, two customers accounted in the aggregate for approximately 11% and 16% of net sales of the Benchtop Laboratory Equipment Operations (15% and 11% of the Company’s total revenues).
3.
Fair value measurements do not include transaction costs.
Level 1 - Inputs that are based upon unadjusted quoted prices for identical instruments traded in active markets.


item2.txt
Item 2.
Forward-Looking statements.
Consequently, no forward-looking statement can be guaranteed.
Overview.
The overall gross profit percentage for the three months ended December 31, 2017 was 40.5% compared to 29.6% for the three months ended December 31, 2016.
The catalyst research instruments was negatively impacted by the lower sales.
Selling expenses for the three months ended December 31, 2017 decreased $9,600 (4.3%) to $214,600 from $224,200 for the three months ended December 31, 2016, due to lower sales related expenses for the Catalyst Research Instruments Operations.
Total other income decreased by $2,200 (26.5%) from $8,300 for the three months ended December 31, 2016 to $6,100 for the three months ended December 31, 2017 due to lower interest on its investment securities.
Selling expenses for the six months ended December 31, 2017 decreased $25,300 (5.7%) to $415,600 from $440,900 for the six months ended December 31, 2016, due to lower sales related expenses for the Catalyst Research Instruments Operations.
Net cash used in investing activities was $84,600 for the six months ended December 31, 2017 compared to $27,000 used during the six months ended December 31, 2016 principally due to new capital equipment purchased during the current year period by the Benchtop Laboratory Equipment Operations.
The Company has a Demand Line of Credit through June 2018 with First National Bank of Pennsylvania which provides for borrowings of up to $300,000 for regular working capital needs, bearing interest at prime, currently 4.5%.


item4.txt
Changes in Internal Control Over Financial Reporting.


